Connection

Joseph Campbell to Substance Withdrawal Syndrome

This is a "connection" page, showing publications Joseph Campbell has written about Substance Withdrawal Syndrome.
  1. Inverse agonists of the 5-HT2A receptor reduce nicotine withdrawal signs in rats. Neurosci Lett. 2019 11 20; 713:134524.
    View in: PubMed
    Score: 0.156
  2. A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat. Neurosci Lett. 2018 09 25; 684:98-103.
    View in: PubMed
    Score: 0.143
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.